Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography
Murray, Katie M., Parker, William P. , Stephany, Heidi A., Redger, Kirk, Mirza, Moben, Lopez‐Corona, Ernesto, Holzbeierlein, Jeffrey M., Lee, Eugene K. , Parker, William , Murray, Katie M.

Arab Journal of Urology | December 29, 2015 | Volume: 14 | Issue: 1 | Pages: 37-43

10.1016/j.aju.2015.11.002 | PMID 26966592 Get It

Incidence and risk factors of acute kidney injury following transcatheter aortic valve replacement
Cheungpasitporn, Wisit , Srivali, Narat , Kittanamongkolchai, Wonngarm , Greason, Kevin L. , Thongprayoon, Charat , Kashani, Kianoush , Cheungpasitporn, Wisit , Srivali, Narat

Nephrology | December 29, 2015 | Volume: 21 | Issue: 12 | Pages: 1041-1046

10.1111/nep.12704 | PMID 26714182 Get It

AbstractAimThis study aimed to determine the incidence and risk factors of acute kidney injury (AKI) following transcatheter aortic valve replacement (TAVR).MethodsWe included all adult patients undergoing TAVR for aortic stenosis from 1 January 2008 to 30 June 2014 at a tertiary referral hospital. AKI was defined based on Kidney Disease: Improving Global Outcomes criteria. We performed a multivariate logistic regression to identify factors associated with post‐procedural AKI occurrence.ResultsThree hundred eighty‐six patients met the inclusion criteria, of which 106 (28%) developed AKI. In multivariate analysis, AKI development was independently associated with a transapical approach (odds ratio (OR), 2.81; 95% confidence interval (CI), 1.72–4.65 compared with transfemoral approach) and the need for an intra‐aortic balloon pump (OR, 9.11; 95% CI, 1.77–68.29). Higher baseline renal function (OR, 0.78 per 10 mL/min per 1.73 m2 increment in glomerular filtration rate; 95% CI, 0.68–0.87) was significantly associated with a decreased risk of AKI. After adjustment for the Society of Thoracic Surgeons' risk score, post‐procedural AKI development remained significantly associated with an increased in‐hospital (OR, 4.74; 95% CI, 1.39–18.48) and 6‐month mortality (OR, 4.66; 95% CI, 2.32–9.63).ConclusionIn a cohort of patients undergoing TAVR for aortic stenosis, AKI commonly occurred and was significantly associated with increased mortality. Baseline renal function, procedure approach and the need for circulatory support were important predictive factors for post‐procedural AKI occurrence.
Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges
O’Bryant, Sid E. , Lista, Simone , Zhang, Fan , Hall, James , Lovestone, Simon , Gupta, Veer Bala , Graff‐Radford, Neill, Martins, Ralph N. , Jeromin, Andreas, Kling, Mitchel A. , Hampel, Harald , Area, ISTAART Blood Based Biomarker Professional Interest, Rissman, Robert A. , Edwards, Melissa , Zetterberg, Henrik , Graff‐Radford, Neill, Waring, Stephen C. , Oh, Esther S , Baker, Laura D. , Area, ISTAART Blood Based Biomarker Professional Interest, O'Bryant, Sid

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | December 29, 2015 | Volume: 3 | Issue: 1 | Pages: 27-34

10.1016/j.dadm.2015.12.003 | PMID 27019866 Get It

AbstractIntroductionThis study investigated the comparability of potential Alzheimer's disease (AD) biomarkers across blood fractions and assay platforms.MethodsNonfasting serum and plasma samples from 300 participants (150 AD patients and 150 controls) were analyzed. Proteomic markers were obtained via electrochemiluminescence or Luminex technology. Comparisons were conducted via Pearson correlations. The relative importance of proteins within an AD diagnostic profile was examined using random forest importance plots.ResultsOn the Meso Scale Discovery multiplex platform, 10 of the 21 markers shared >50% of the variance across blood fractions (serum amyloid A R2 = 0.99, interleukin (IL)10 R2 = 0.95, fatty acid‐binding protein (FABP) R2 = 0.94, I309 R2 = 0.94, IL‐5 R2 = 0.94, IL‐6 R2 = 0.94, eotaxin3 R2 = 0.91, IL‐18 R2 = 0.87, soluble tumor necrosis factor receptor 1 R2 = 0.85, and pancreatic polypeptide R2 = 0.81). When examining protein concentrations across platforms, only five markers shared >50% of the variance (beta 2 microglobulin R2 = 0.92, IL‐18 R2 = 0.80, factor VII R2 = 0.78, CRP R2 = 0.74, and FABP R2 = 0.70).DiscussionThe current findings highlight the importance of considering blood fractions and assay platforms when searching for AD relevant biomarkers.
Transoral robotic medial hypopharyngectomy: Surgical technique
Sims, John R. , Robinson, Nathaniel L. , Moore, Eric J. , Janus, Jeffrey R.

Head & Neck | December 29, 2015 | Volume: 38 | Issue: S1 | Pages: No page available

10.1002/hed.24360 | PMID 26714289 Get It

AbstractBackgroundTransoral robotic surgery (TORS) has been shown to be both feasible and oncologically sound for use in early T classification hypopharyngeal cancers. The purpose of this study was to present our surgical technique for performing a transoral robotic hypopharyngectomy.MethodsA 48‐year‐old man with a T2, N2a, M0 squamous cell carcinoma of the hypopharynx underwent a transoral robotic hypopharyngectomy and a left select neck dissection of levels II to IV.ResultsThe hypopharyngeal tumor was removed en bloc after circumferential cuts were made until the tumor was finally amputated from the apex of the piriform sinus. Negative margins were achieved. A left select neck dissection was performed. The patient was tolerating an oral diet and his tracheostomy tube was decannulated before discharge.ConclusionTORS offers improved manual dexterity and tumor manipulation over conventional transoral approaches to hypopharyngeal cancers. It is both a feasible and effective method for certain early‐stage hypopharyngeal cancers. © 2015 Wiley Periodicals, Inc. Head Neck 38: E2127–E2129, 2016
Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes
Cartin‐Ceba, Rodrigo , Diaz-Caballero, L.A. , Al‐Qadi, Mazen O. , Τryfon, Stavros , Ytterberg, Steven R. , Fervenza, Fernando C. , Specks, Ulrich

Arthritis & Rheumatology | December 29, 2015 | Volume: 68 | Issue: 6 | Pages: 1467-1476

10.1002/art.39562 | PMID 26713723 Get It

Objective To identify predictors of respiratory failure and to evaluate the therapeutic efficacy of plasma exchange (PE) and of rituximab versus cyclophosphamide in a cohort of patients with diffuse alveolar hemorrhage (DAH) secondary to antineutrophil cytoplasmic antibody–associated vasculitis (AAV) with or without respiratory failure. Methods We performed a single‐center historical cohort study of all consecutive patients with AAV‐associated DAH who were evaluated over a 16‐year period. Logistic regression models were developed to examine the predictive role of the baseline clinical characteristics for the development of respiratory failure, and for the effect of PE and remission induction therapy on the main outcome (complete remission at 6 months). Results Seventy‐three patients with DAH were identified, and 34 of them experienced respiratory failure. The degree of hypoxemia upon initial presentation, a higher percentage of neutrophils in the bronchoalveolar lavage fluid cell count, and higher C‐reactive protein levels were independently associated with the development of respiratory failure. PE was not associated with achieving complete remission at 6 months, with an odds ratio (OR) of 0.49 (95% confidence interval [95% CI] 0.12–1.95) ( P = 0.32). Rituximab treatment was independently associated with achieving complete remission at 6 months (OR 6.45 [95% CI 1.78–29], P = 0.003). Conclusion Our findings indicate that the most important predictor of respiratory failure in patients with DAH secondary to AAV is the degree of hypoxemia upon presentation. No clear benefit of the addition of PE to standard remission induction therapy was demonstrated. Complete remission by 6 months was achieved at a higher rate with rituximab than with cyclophosphamide in patients with DAH secondary to AAV, including those needing mechanical ventilation.
Literature‐based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses
Laniosz, Valerie, Lehman, Julia S. , Poland, Gregory A., Wetter, David A. , Poland, Gregory A. , Lehman, Julia S

International Journal of Dermatology | December 29, 2015 | Volume: 55 | Issue: 6 | Pages: 599-607

10.1111/ijd.13140 | PMID 26711431 Get It

AbstractAutoimmune bullous diseases, such as pemphigus, pemphigoid, and dermatitis herpetiformis, are uniquely associated with vulnerability in the mucocutaneous barrier against infection. The management of immunobullous diseases is complex and may at times require immunosuppressive medications. Iatrogenic immunosuppression may increase susceptibility to vaccine‐preventable illnesses. Currently, there are no guidelines to assist the clinician treating patients with immunobullous disease regarding the delivery of various vaccinations. The aim of this review is to provide recommendations for immunization in the unique setting of immunobullous disease. Recommendations are based on careful review of the literature in other conditions requiring iatrogenic immunosuppression, as well as the most recent Centers for Disease Control and Prevention guidelines. Immunization with nonlive vaccines appears to be a safe and effective strategy for preventing infection in the particularly susceptible patient with immunobullous disease. Opportunities for live vaccine administration may become available at lower levels of immune suppression or during clinical remission when immunosuppressive regimens can be reduced. Anticipatory vaccination before the initiation of iatrogenic immunosuppression is ideal. Although immunologic response to vaccination may be suboptimal during immunosuppression, nonlive vaccination is strongly recommended for this patient population.
Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
Zhu, Yi , Tchkonia, Tamar , Fuhrmann‐Stroissnigg, Heike , Dai, Haiming , Ling, Yuanyuan, Pirtskhalava, Tamar , Giorgadze, Nino, Johnson, Kurt O. , Giles, Cory B. , Wren, Jonathan D. , Niedernhofer, Laura J. , Robbins, Paul D. , Kirkland, James L. , Tchkonia, Tamara, Stout, Michael B, Stout, Michael B , Tchkonia, T , Niedernhofer, Laura J , Robbins, Paul D , Zhu, Yi , Dai, Haiming

Aging Cell | December 29, 2015 | Volume: 15 | Issue: 3 | Pages: 428-435

10.1111/acel.12445 | PMID 26711051 Get It

Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics
Ruddy, Kathryn J. , Risendal, Betsy , Garber, Judy E. , Partridge, Ann H.

Journal of Clinical Oncology | December 29, 2015 | Volume: 34 | Issue: 6 | Pages: 539-541

10.1200/jco.2015.63.5375 | PMID 26712228 Get It

Antibiofilm Activity of Electrical Current in a Catheter Model
Voegele, Paul, Badiola, Jon , Schmidt-Malan, Suzannah M., Karau, Melissa J. , Greenwood‐Quaintance, Kerryl E. , Mandrekar, Jayawant N. , Patel, Robin , Patel, Robin

Antimicrobial Agents and Chemotherapy | December 29, 2015 | Volume: 60 | Issue: 3 | Pages: 1476-1480

10.1128/aac.01628-15 | PMID 26711752 Get It

ABSTRACT Catheter-associated infections are difficult to treat with available antimicrobial agents because of their biofilm etiology. We examined the effect of low-amperage direct electrical current (DC) exposure on established bacterial and fungal biofilms in a novel experimental in vitro catheter model. Staphylococcus epidermidis , Staphylococcus aureus , Escherichia coli , Pseudomonas aeruginosa , and Candida parapsilosis biofilms were grown on the inside surfaces of polyvinyl chloride (PVC) catheters, after which 0, 100, 200, or 500 μA of DC was delivered via intraluminally placed platinum electrodes. Catheter biofilms and intraluminal fluid were quantitatively cultured after 24 h and 4 days of DC exposure. Time- and dose-dependent biofilm killing was observed with all amperages and durations of DC administration. Twenty-four hours of 500 μA of DC sterilized the intraluminal fluid for all bacterial species studied; no viable bacteria were detected after treatment of S. epidermidis and S. aureus biofilms with 500 μA of DC for 4 days.
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
Shen, Weiwei , Patnaik, Mrinal M. , Ruiz, Autumn, Russell, Stephen J. , Peng, Kah-Whye , Schulze, Autumn J. , Russell, Stephen J

Blood | December 28, 2015 | Volume: 127 | Issue: 11 | Pages: 1449-1458

10.1182/blood-2015-06-652503 | PMID 26712908 Get It

Key Points IV therapy with oncolytic VSV-IFNβ-NIS virus extends survival of immunocompetent mice with AML. The therapeutic outcome of VSV-IFNβ-NIS–treated mice with AML is augmented by anti-PD-L1 immunotherapy.